Kaya (KAYS) & Its Competitors Financial Survey

Kaya (OTCMKTS:KAYS) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its rivals? We will compare Kaya to related businesses based on the strength of its institutional ownership, valuation, dividends, profitability, earnings, risk and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Kaya and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kaya	0	0	0	0	N/A
Kaya Competitors	6394	18736	44646	917	2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 82.78%. Given Kaya’s rivals higher probable upside, analysts clearly believe Kaya has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

44.7% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 23.5% of Kaya shares are owned by insiders. Comparatively, 14.2% of shares of all “Pharmaceutical preparations” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Kaya and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Kaya	$200,000.00	$1.61 million	-2.35
Kaya Competitors	$1.67 billion	$146.43 million	-1.64

Kaya’s rivals have higher revenue and earnings than Kaya. Kaya is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Kaya has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. Comparatively, Kaya’s rivals have a beta of 1.09, suggesting that their average share price is 9% more volatile than the S&P 500.

Profitability

This table compares Kaya and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kaya	821.43%	-9.57%	638.26%
Kaya Competitors	-2,459.06%	-249.83%	-30.60%

Summary

Kaya rivals beat Kaya on 6 of the 10 factors compared.

About Kaya

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.